Single incision laparoscopic surgery (SILS) may be even less invasive to a patient than conventional laparoscopic surgery (CLS). aim of the study of the applicability of the procedure, the first 1½ year of experiences and comparison with CLS for colonic cancer resections material and methods. Since November 2010 SILS procedures was trained by two surgeons. Data was prospectively registered. Each of all colonic cancer resections was blindly matched with two patients operated with CLS within the period from 2009-2011 with respect of procedure, gender, T stadium, age, ASA score and BMI. In the routine accelerated "fast track" program the use of additional opioids was registered. results. SILS was performed in 18 patients with cancer resections. Comparisons between the SILS procedures and the matched 36 CLS operations showed no significant difference in operation time, blood loss, lymph node harvest and hospital stay, but length of vascular pedicle was significantly larger in SILS procedures. Although only 50% of SILS patients received opioids postoperatively, this was not significantly different from the 71% receiving opioids in the CLS group, and similarly no significant difference in number of administrations or amount of opioids were seen. conclusion. With reservation of a small study group we find SILS is like worthy to CLS in colorectal cancer surgery and a benefit in postoperative recovery and pain is possible, but has to be investigated in larger randomised studies.
Single incision procedures are evolving as part of minimally invasive surgery. In abdominal surgery there has been a rapid progression with cholecystectomies. Here, besides the cosmetic advantage, a randomised study has shown less postoperative pain with single incision laparoscopic surgery (SILS) compared with conventional laparoscopic surgery (CLS) (1), although intermediate results from another randomised study could not confirm this (2) . For colorectal procedures, retrospective studies showed that the benefits from SILS might encounter faster postoperative recovery, less use of narcotics and shorter hospital stay compared with CLS (3, 4) . A recent randomised study confirmed these results (5) .
The aim of the study has been to summarise the experience of two senior surgeons with SILS colonic cancer surgery from December 2010 until June 2012 and to compare the results with a control group having CLS performed
MATERIAL AND METHODS
The first SILS procedures included in our series were selected after clinical judgement and CT evaluation of the patients. SILS was not performed when tumour was more than 6 cm in diameter or deemed to grow into surroundings, if body mass index (BMI) > 30 or American Society of Anaesthesiologists (ASA) group >II. After some experience these criteria's were limited to only tumour size above 6 cm. A three cm incision was used to insert a Covidien® port or Apgar® gel port in the umbilicus. The instruments used were the same as in routine CLS, although a five mm optic was used instead of routine ten mm. Extra ports were used whenever progression in surgery was needed. First choice was a Minilap (Stryker®) which makes incisions of only 2,3 mm; second choice was a five mm port (Covi-dien®).
Dissection was performed medial to lateral with exposure of the central vessels to the tumour-bearing part of colon. With tumours in the right colon the ileocolic vessels were divided close to the confluence with the superior mesenteric vein and right colic vein (if present) including right branches from medial colic vessels. With sigmoid tumours the inferior mesenteric vessels were divided close to the branching of, but with preserving of the left colic vein. This is also the standard procedure with CLS in our institution.
All patient data were registered prospectively. Conversion from SILS procedures to a procedure with more than one port was considered a "conversion" as well as conversion to laparotomy. Any lengthening of the incision greater than required to extract the specimen was considered a conversion from both SILS and CLS procedures as classified in previous studies (6).
Matching CLS control patients
From our patients series in the Danish Colorectal Cancer Database 2009-2011 two matched controls per SILS patients with respect to gender and surgical procedure were extracted. Matching with respect to age, ASA, BMI and T stage was intended, but not always fully possible due to small numbers. The matching was done blinded to other patientdata not used in the matching. These data were extracted only after best matching.
Pain scores and medications
Local anaesthetic (bupivacaine 0,5%, three ml) was routinely injected initiallysubcutane-ously at every port-incision in both SILS and CLSand 10 ml was injected around the specimen extraction site at the end of the operation. According to our routine "fast track" course all patients had early oral feeding, early mobilisation, laxatives,paracetamol, gabapentin 300 mg twice for two days, opioids only on demand and drain and tubes were avoided. Pain was measured on a visual analogue scale (VAS-score) and when the patient scored more than four; morphine was given intravenously as five mg. To avoid the bias of longer hospital stay on use of opioids, the registration was only made for the first two postoperative days.
Statistics
Results are shown as median and range. Difference in variables between SILS and CLS was tested by non-parametric tests using χ 2test and Mann-Whitney U-test. Significant level was p < 0.05.
RESULTS
Eighteen patients were operated within the first 18 months with SILS colorectal cancerresection procedures. The SILS procedures were nine sigmoid resections, two left hemicolectomies and seven right hemicolectomies. The matching of the SILS procedures with 36 CLS procedures resulted in no statistical significant difference with respect of patient-and tumour factors as seen in tab. 1. Surgeon experience was not different in the two groups as one of the two SILS-surgeons was participating in 22 of the 36 operations performed in the CLS group. Five different surgeons performed CLS.
In three SILS cases an extra port was needed and in one case (left hemicolectomy) the port was extended due to dissection difficulty and large tumour size (11% conversion to CLS and 6% conversion to open surgery, tab. 2). In the CLS group four cases were converted (11%) to open procedure due to difficult anatomy. Other per-and postoperative results including oncological quality data are shown in tab. 2. The only statistical difference observed between the SILS and CLS groups was a longer vascular pedicle in SILS patients. A # extension is lenthening of the incision greater than required to extract the specimen * number of patients reduced due to missing data (dissection in CLS) and **due to one patient receiving epidural pain catheder (opioids in CLS) description of the anatomical dissection plane (mesocolic, intramesocolic or intramuscular) was introduced in Denmark at the end of 2009 and therefore these data were not present in 17 CLS patients. In the SILS group, one patient (right hemicolectomy) had a peroperatively unrecognized lesion of the terminal ileum and suffered from peritonitis. He was re-operated with an ileostomy 3 rd postoperative day and the rest of the course was uneventful. One patient (right hemicolectomy) had anastomotic leakage and was re-operated with creation of ileostomies, but otherwise uneventful. One patient suffered from ileus and was operated on the 7 th postoperative day with an uneventful course. In the CLS group, six patients had peroperative lesions: One unrecognized pancreatic tale lesion with peritonitis and fatal course, five recognized lesions; one of the bladder and one of the spleen with bleed-ing -both handled peroperatively by conversion; and three lesions of the small bowel and mesentery also handled peroperatively, one by conversion. Also in the CLS group two patients had anastomotic leakages, both re-operated with diverting stomas. One of these patients had a septic event and died from multi-organfailure in the intensive care unit on 20 th postoperative day. One patient had early stenosis of the anastomosis with subileus evolving to ileus with operation on 60 th postoperative day.
DISCUSSION
In this study we present the results of the first one and a half year experience with SILS procedures for colonic cancer. In a matched comparison with CLS performed within the last three years we find no other difference in quality or complication rate than a little longer pedicle height of the resections with SILS. However, this may not be due to a better dissection with SILS procedures. The difference is probably a result of the surgeon awareness of the importance of "high tie" which has been discussed during the last years and enforced by the evaluation of the dissection plane from 2010. Furthermore, only two specialists who may bias the result by better interaction on the dissection method performed SILS. This may also be a bias on other variables although specialized laparoscopic surgeons performed CLS as well.
Colonic cancer resections with SILS may be technical difficult and more time consuming than CLS (3, 6) . In previous reports the duration of SILS colonic resection ranged from 75 minutes (7) to 274 minutes (3), which is comparable to the 171 minutes in the present series. However, the SILS procedures were highly selected and therefore the conclusions should be drawn with caution. In a randomised study of 2 x 25 patients (5) no statistical significance were observed (155 min in SILS patients vs. 124 min in CLS patients), but may be the difference had reached significance in a larger series.
There were four conversions (three to CLS and one with an expansion of the incision to 12 cm) among SILS procedures leaving a conversion rate of 22%. This is somewhat higher than an overall conversion rate of 7% seen in a systematic review of 378 colonic SILS procedures (8) . In early reports of SILS colonic cancer resection a rate of 17% were seen (6, 9) , and a high conversion rate may be a result of our limited experience.
In colorectal cancer the number of analysed lymph nodes, which is dependent on both the extent of resection and eagerness of the pathologist´s examination, is a prognostic factor with respect to survival (10) . A lymph node range of 13.5 -27 reported in a recent review of colorectal SILS resections (8) rendering the number of 17 in our study in the low end. The number of detectable lymph nodes may be dependent on stage (11) . Median 24 lymph nodes were harvested in a study of SILS resections including 49% stage III colon cancers (3), but in our study only 28% of SILS resections had stage III (lymph node metastases). The present results may be more comparable to studies of SILS resections including approximately 40% stage III cancers harvesting median 15 and 16 lymph nodes (5, 12) and 33% stage III cancers harvesting median12 lymph nodes (7) . Also the specimen length in the present study is comparable to a range of 17 -24 cm's seen in other SILS reports (7, (13) (14) (15) , and the SILS cancer specimens were categorized as mesocolic resected in 67% of the procedures which is comparable to a rate of 75% seen in a Danish hospital after implementation of a surgical educational training program in complete mesocolic excision with central vascular ligation (16). The pedicle length of median 9 cmwas significantly more than obtained with CLS in the present study. Furthermore, as pedicle length of SILS resections are comparable to 82 mm seen in the above-mentioned surgical training programme with a greater lymph node yield than standard practice(16), the oncological quality in the present study of SILS procedures seems acceptable.
Intra-operative lesions with laparoscopic surgery is a matter of concern (17). One SILS patient suffered a small bowel lesion not recognized under the operation and similar events with SILS have been reported previously (3) . In SILS surgery it is an inherent problem that there are more blind angels compared to CLS and therefore a search of unrecognized lesions of bowel or adjacent organs is mandatory. There are more blind angels in SILS than compared with CLS.
Half of the patients in our study had to have additional opioid medication postoperatively, which is lower, but not significantly different from 71% in CLS patients. We have identified five reports on postoperative pain after SILS colectomies (3-5, 7, 9) of which three studies showed less pain after SILS compared to CLS. Two of the five studies reported solely on pain scores (4, 7), two reported solely on opioid use (3, 9) and the only randomised study reported both pain score and opioid use (5) . In that study a lower median postoperative wound pain score at postoperative day one and two were observed, but no difference in total postoperative morphine use occurred (5) . In one of the previous studies of postoperative opioid use (3, 5, 9) a significant reduction in the SILS group was reported(3),but the standard pain treatment was different from our procedure.Thus, we do not use continuous intravenous fentanyl as in the study of Kim et al (3) . Furthermore, we use local anaesthetics in the ports of both SILS and CLS procedures and although the effect is only 6 hours postoperatively it may contribute to a less measurable difference in a small study population.
The hospital stay was median three days in the present study of SILS colon resections, which also is the median stay for the patients operated with routine CLS in our department. In the studies including postoperative pain measurements in SILS vs. CLS it showed LOS from median three to seven days (3, 4) . Significant reductions in LOS were seen in three (3-5) of the five studies. As these three studies also included the largest number of patients, it may be suggested that SILS may have benefits in earlier recovery when compared to CLS in even larger study populations of colorectal resections. In our experience the most important factors for early hospital release in an uncomplicated patient course may be pain, the use of opioids and the side effects from these opioids; i.e. postoperative nausea and ileus. Although the number of patients in our study may be too small to make conclusions of postoperative pain release and LOS, we find it possible that SILS may be beneficial in the recovery period after resection of small colon cancers. Along with reports on survival and other factors as postoperative adhesions and port hernias, we await eagerly the results from new large randomised studies of SILS vs. CLS in colorectal procedures.
In conclusion, we find the SILS method both feasible and usable in colorectal surgery and safe in cancer resections of small tumours in a small selected study population. The need of additional ports may be high in the learning period. According to the literature, it seems possible that SILS may have advances in postoperative recovery compared with CLS, but this has to be proven in a proper and larger blinded randomised study.
